BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1348044)

  • 1. Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians.
    Bétard C; Kessling AM; Roy M; Chamberland A; Lussier-Cacan S; Davignon J
    Hum Genet; 1992 Mar; 88(5):529-36. PubMed ID: 1348044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine mapping of low-density lipoprotein receptor gene by genetic linkage on chromosome 19p13.1-p13.3 and study of the founder effect of four French Canadian low-density lipoprotein receptor gene mutations.
    Couture P; Morissette J; Gaudet D; Vohl MC; Gagné C; Bergeron J; Després JP; Simard J
    Atherosclerosis; 1999 Mar; 143(1):145-51. PubMed ID: 10208489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of genetic variability in the nondeletion LDL-receptor allele on phenotypic variation in French-Canadian familial hypercholesterolemia heterozygotes sharing a 'null' LDL-receptor gene defect.
    Bétard C; Kessling AM; Roy M; Davignon J
    Atherosclerosis; 1996 Jan; 119(1):43-55. PubMed ID: 8929255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L; Qiu S; Genest J
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common low-density lipoprotein receptor mutations in the French Canadian population.
    Leitersdorf E; Tobin EJ; Davignon J; Hobbs HH
    J Clin Invest; 1990 Apr; 85(4):1014-23. PubMed ID: 2318961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
    Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
    Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotypes identified by 10 DNA restriction fragment length polymorphisms at the human low density lipoprotein receptor gene locus.
    Kotze MJ; Langenhoven E; Retief AE; Seftel HC; Henderson HE; Weich HF
    J Med Genet; 1989 Apr; 26(4):255-9. PubMed ID: 2565980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial hypercholesterolemia in French-Canadians: taking advantage of the presence of a "founder effect".
    Davignon J; Roy M
    Am J Cardiol; 1993 Sep; 72(10):6D-10D. PubMed ID: 8213499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypercholesterolemia in the Finnish north Karelia. A molecular, clinical, and genealogical study.
    Vuorio AF; Turtola H; Piilahti KM; Repo P; Kanninen T; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3127-38. PubMed ID: 9409302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia.
    Hobbs HH; Brown MS; Russell DW; Davignon J; Goldstein JL
    N Engl J Med; 1987 Sep; 317(12):734-7. PubMed ID: 3627182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haplotype analysis at the low density lipoprotein receptor locus in normal and familial hypercholesterolemia Norwegian subjects.
    Rødningen OK; Leren TP; Røsby O; Tonstad S; Ose L; Berg K
    Clin Genet; 1993 Oct; 44(4):214-20. PubMed ID: 7903228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a second "French Canadian" LDL receptor gene deletion and development of a rapid method to detect both deletions.
    Ma YH; Bétard C; Roy M; Davignon J; Kessling AM
    Clin Genet; 1989 Oct; 36(4):219-28. PubMed ID: 2805380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Trp23-Stop and Trp66-Gly mutations in the LDL receptor gene: common causes of familial hypercholesterolemia in Denmark.
    Jensen HK; Jensen LG; Hansen PS; Faergeman O; Gregersen N
    Atherosclerosis; 1996 Feb; 120(1-2):57-65. PubMed ID: 8645371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four DNA polymorphisms in the LDL-receptor gene and their use in diagnosis of familial hypercholesterolemia.
    Schuster H; Stiefenhofer B; Wolfram G; Keller C; Humphries S; Huber A; Zöllner N
    Hum Genet; 1989 Apr; 82(1):69-72. PubMed ID: 2565869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.
    Wang J; Huff E; Janecka L; Hegele RA
    Hum Mutat; 2001 Oct; 18(4):359. PubMed ID: 11668627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seven DNA polymorphisms in the LDL receptor gene: application to the study of familial hypercholesterolemia in Spain.
    Chaves FJ; Puig O; García-Sogo M; Real J; Gil JV; Ascaso J; Carmena R; Armengod ME
    Clin Genet; 1996 Jul; 50(1):28-35. PubMed ID: 8891383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews.
    Meiner V; Landsberger D; Berkman N; Reshef A; Segal P; Seftel HC; van der Westhuyzen DR; Jeenah MS; Coetzee GA; Leitersdorf E
    Am J Hum Genet; 1991 Aug; 49(2):443-9. PubMed ID: 1867200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of three DNA polymorphisms of the LDL receptor gene in the diagnosis of familial hypercholesterolemia.
    Daga A; Mattioni T; Balestreri R; Coviello DA; Corte G; Bertolini S
    Hum Genet; 1990 Apr; 84(5):412-6. PubMed ID: 1969842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men.
    Gaudet D; Vohl MC; Couture P; Moorjani S; Tremblay G; Perron P; Gagné C; Després JP
    Atherosclerosis; 1999 Mar; 143(1):153-61. PubMed ID: 10208490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.